XOMAP Q3 2020 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$557,000-93.7% YoY

Gross Profit

$523,00093.9% margin

Operating Income

-$3M-482.8% margin

Net Income

-$1M-193.4% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+25.5%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$86M

Total Liabilities

$48M

Stockholders' Equity

$38M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$557,000	$9M	-93.7%
Gross Profit	$523,000	$9M	-94.0%
Operating Income	-$3M	$3M	-193.0%
Net Income	-$1M	$3M	-133.9%